Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Oncotherpapy Science Inc | 30O | Sep 30, 2024 | 0.19 | -3.08 |
OncoZenge | 8LY | Sep 30, 2024 | 0.56 | +4.28 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | Sep 30, 2024 | 0.60 | 0.00 |
Onde S.A. | 0XF | Sep 30, 2024 | 2.52 | +0.40 |
Ondine Biomedical Inc | VF5 | Sep 30, 2024 | 0.06 | 0.00 |
ONE Gas, Inc. | OG9 | Sep 30, 2024 | 65.50 | 0.00 |
One Liberty Properties, Inc. | O1A | Sep 30, 2024 | 24.40 | +0.83 |
One Media iP Group Plc | 1M9 | Sep 30, 2024 | 0.04 | 0.00 |
One More Level S.A. | 1OJ | Sep 30, 2024 | 0.34 | +3.17 |
One Stop Systems, Inc. | 5MU | Sep 30, 2024 | 2.08 | +4.52 |
OneApex Limited | CWF | Sep 30, 2024 | 0.08 | 0.00 |
ONEFLOW AB | L58 | Sep 30, 2024 | 3.29 | +2.17 |
OneMain Holdings, Inc. | 0S1 | Sep 30, 2024 | 41.59 | +0.14 |
ONEOK, Inc. | ONK | Sep 30, 2024 | 81.08 | +1.81 |
OneSpan Inc. | VDY | Sep 30, 2024 | 14.30 | -0.69 |
OneSpaWorld Holdings Limited - | ORW | Sep 30, 2024 | 14.60 | -0.68 |
Onex Corp. | ONE | Sep 30, 2024 | 63.00 | -1.56 |
Ono Pharmaceutical Co. Ltd | ON4 | Sep 30, 2024 | 11.90 | +1.71 |
ONTEX GROUP NV EO -,01 | OT7 | Sep 30, 2024 | 9.01 | 0.00 |
Onto Innovation Inc. | NNM | Sep 30, 2024 | 192.00 | -3.52 |
Ontrak | HY10 | Sep 30, 2024 | 1.88 | 0.00 |
Ontrak, Inc. - 9.50% Series A Cumulative Perpetual Preferred | HY1 | Sep 30, 2024 | 0.19 | +13.10 |
Onward Medical NV | 63E | Sep 30, 2024 | 4.88 | +1.46 |
Onxeo | C4X | Sep 30, 2024 | 0.11 | +42.30 |
oOh media Limited | 0OH | Sep 30, 2024 | 0.77 | -2.55 |
OOIL | ORI1 | Sep 30, 2024 | 12.49 | -0.24 |
OP Bancorp | OP3 | Sep 30, 2024 | 10.80 | 0.00 |
OPAP (CR) | GF8 | Sep 30, 2024 | 15.79 | -2.41 |
Opawica Explorations Inc. | OE5 | Sep 30, 2024 | 0.06 | -0.79 |
Open House Co Ltd | O4H | Sep 30, 2024 | 33.80 | -1.74 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.